Sirona Biochem Corp (SBM) - Cash Flow Conversion Efficiency

Latest as of July 2024: 0.160x

Based on the latest financial reports, Sirona Biochem Corp (SBM) has a cash flow conversion efficiency ratio of 0.160x as of July 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-552.59K ≈ $-399.74K USD) by net assets (CA$-3.46 Million ≈ $-2.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Sirona Biochem Corp - Cash Flow Conversion Efficiency Trend (2011–2023)

This chart illustrates how Sirona Biochem Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SBM total debt and obligations for a breakdown of total debt and financial obligations.

Sirona Biochem Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sirona Biochem Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Max Resource Corp V:MAX	-0.139x
Annexin Pharmaceuticals AB ST:ANNX	-0.380x
Delixy Holdings Limited Ordinary Shares NASDAQ:DLXY	N/A
Energoinstal S.A. WAR:ENI	0.031x
Biovie Inc NASDAQ:BIVI	-0.230x
Calibre PA:ALWIN	0.411x
Superior Resources Ltd AU:SPQ	-0.017x
COCRYSTAL PHARMA NEW O.N. F:8CC	N/A

Annual Cash Flow Conversion Efficiency for Sirona Biochem Corp (2011–2023)

The table below shows the annual cash flow conversion efficiency of Sirona Biochem Corp from 2011 to 2023. For the full company profile with market capitalisation and key ratios, see SBM market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-10-31	CA$-2.51 Million ≈ $-1.82 Million	CA$-1.76 Million ≈ $-1.27 Million	0.700x	+106.89%
2022-10-31	CA$214.51K ≈ $155.18K	CA$-2.18 Million ≈ $-1.58 Million	-10.151x	-145.63%
2021-10-31	CA$-97.02K ≈ $-70.18K	CA$-2.16 Million ≈ $-1.56 Million	22.246x	+149.92%
2020-10-31	CA$47.40K ≈ $34.28K	CA$-2.11 Million ≈ $-1.53 Million	-44.564x	-2641.24%
2019-10-31	CA$2.19 Million ≈ $1.58 Million	CA$-3.56 Million ≈ $-2.57 Million	-1.626x	-719.47%
2018-10-31	CA$-2.26 Million ≈ $-1.64 Million	CA$-593.35K ≈ $-429.22K	0.262x	-78.57%
2017-10-31	CA$-2.04 Million ≈ $-1.48 Million	CA$-2.50 Million ≈ $-1.81 Million	1.225x	+191.01%
2016-10-31	CA$1.56 Million ≈ $1.13 Million	CA$-2.10 Million ≈ $-1.52 Million	-1.346x	+5.71%
2015-10-31	CA$2.15 Million ≈ $1.55 Million	CA$-3.06 Million ≈ $-2.22 Million	-1.427x	-37.36%
2014-10-31	CA$1.79 Million ≈ $1.30 Million	CA$-1.86 Million ≈ $-1.35 Million	-1.039x	+10.78%
2013-10-31	CA$2.15 Million ≈ $1.55 Million	CA$-2.50 Million ≈ $-1.81 Million	-1.164x	+7.70%
2012-10-31	CA$1.70 Million ≈ $1.23 Million	CA$-2.15 Million ≈ $-1.55 Million	-1.261x	-35.27%
2011-10-31	CA$2.72 Million ≈ $1.97 Million	CA$-2.54 Million ≈ $-1.84 Million	-0.933x	--

About Sirona Biochem Corp

V:SBM Canada Biotechnology

Market Cap

$11.23 Million

CA$15.53 Million CAD

Market Cap Rank

#26583 Global

#1112 in Canada

Share Price

CA$0.06

Change (1 day)

+0.00%

52-Week Range

CA$0.06 - CA$0.06

All Time High

CA$0.66